GlassScriptPhysician profile
Sunil K Reddy
NPI 1326003641
$4,451.69
in general payments reported to CMS, 2019-2025
22 companies · $571 in 2025
The $571 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $119 · 2021: $369 · 2022: $854 · 2023: $773 · 2024: $1,383 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,412 · Travel and Lodging: $301 · Education: $13.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,411.69 |
| Travel and Lodging | $300.91 |
| Education | $13.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,335.83 | 2019-2025 | |
| Abbott Laboratories | $649.02 | 2022-2025 | Aveir, Ensite, Jot Dx |
| Gilead Sciences, INC. | $551.39 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $323.52 | 2019-2025 | Entyvio, Eohilia |
| Braintree Laboratories, INC. | $269.42 | 2019-2023 | Sutab |
| Merck Sharp & Dohme LLC | $238.59 | 2021-2024 | Dificid, Zinplava |
| Biosense Webster, INC. | $177.86 | 2023-2024 | Carto 3 |
| Janssen Biotech, INC. | $106.34 | 2022-2025 | Stelara, Tremfya, Simponi Aria |
| Boston Scientific Corporation | $104.25 | 2024 | Alliance II, Resolution 360 Ultra Clip |
| Medtronic, INC. | $101.68 | 2025 | Signia, Mycarelink, Micra |
| Qol Medical, LLC | $96.94 | 2024-2025 | Sucraid, Sucraid |
| Ardelyx, INC. | $87.05 | 2022-2024 | Ibsrela |
| Lilly USA, LLC | $83.76 | 2024 | Omvoh |
| Genzyme Corporation | $76.78 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $71.89 | 2019-2023 | Rebyota |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $64.61 | 2024-2025 | Voquezna |
| Vertex Pharmaceuticals Incorporated | $27.06 | 2025 | |
| Ironwood Pharmaceuticals, INC | $20.00 | 2019 | |
| Shire North American Group INC | $19.22 | 2019 | |
| Ethicon US, LLC | $17.94 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.22 | 2021 | |
| Althera Pharmaceuticals LLC | $12.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.